openPR Logo
Press release

Viral Conjunctivitis Pipeline Drugs Market Research Report by Key Players Analysis 2023

09-28-2017 12:57 PM CET | Health & Medicine

Press release from: Transparency Market Research

Viral Conjunctivitis Pipeline Drugs Market

Viral Conjunctivitis Pipeline Drugs Market

The global viral conjunctivitis pipeline drugs market to expand at an exponential CAGR of 69.60% between 2020 and 2023. During this period, the market opportunity is likely to increase up to US$462.4 mn. The U.S. is emerging as the most promising market for viral conjunctivitis therapeutics. The availability of efficient conjunctivitis detection tests such as AdenoPlus, relatively higher cost of medicines than other economies, increasing awareness about the harmful effects of improper consumption of antibiotic, and high expenditure on healthcare are drawing heavy investments from drugmakers, increasing the development of new drugs.

Estimations of analysts indicate that the opportunity in the U.S. market for viral conjunctivitis pipeline drugs will reach US$91.1 mn by 2020 and US$286.4 mn. Besides, the imminent launch of FST-100 in Brazil is projected to strengthen the Brazil market for viral conjunctivitis pipeline drugs in the near future and get it at the second position in the global market by 2020. The U.K. and Germany are likely to follow closely.

The growing demand for targeted drugs for the treatment of viral conjunctivitis has compelled drugmakers to undertake aggressive research strategies to develop efficient therapies alongside developing quick, accurate, as well as affordable viral conjunctivitis detection tests. As there is no drug available for the treatment of viral conjunctivitis in the global market at present, companies need to power up their commercialization activities through agreements and partnerships with major ophthalmic drug manufacturers in order to expand their product portfolios, Transparency Market Research observes in a new study.

Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12251

“In the coming years, a candidate with a wide range of activity but less toxicity and irritation properties will dominate the global viral conjunctivitis pipeline drugs market,” says a TMR analyst. Leading drugmakers operating in this market would need to focus on the development of new products as well as up-gradation of existing products at reasonable costs. Startups would also need to develop innovative products with substantial benefits in comparison to existing pipeline drugs.

Request to Download TOC of the Report: http://www.transparencymarketresearch.com/report-toc/12251

A thumping growth has been witnessed in the incidence of infections across the world. Cases of viral conjunctivitis account for a substantial share of it. Approximately 6 million people get affected by acute conjunctivitis every year. Brazil, Japan, and several countries in Europe have also been reporting a high prevalence of viral conjunctivitis over the past few years.

However, despite such a large pool of patients, there is a huge shortage of efficient drugs for its treatment. These large unmet needs are driving the demand for targeted drugs for viral conjunctivitis, strengthening its therapeutic pipeline. At present, there are no drugs in the late-stage pipeline. The key pipeline drugs, FST-100 and APD-209, are in the second phase of clinical trials. Other drugs are still in the preclinical trials stage.

Global Viral Conjunctivitis Pipeline Drugs Market Report is available @ US$ 5795 : http://www.transparencymarketresearch.com/checkout.php?rep_id=12251

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viral Conjunctivitis Pipeline Drugs Market Research Report by Key Players Analysis 2023 here

News-ID: 745991 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Viral

Viral Inactivation Market Growing Demand of Kits and Reagents Viral Inactivation …
According to Precision Business Insights (PBI), the latest report, the Viral Inactivation market is expected to be worth USD 2.1 billion in 2022, growing at a 12.8% CAGR from 2022 to 2028. The primary driver of the expansion of the global Viral Inactivation market are speedy growth in pharmaceutical and biotechnology industries and strong inclination of R&D investments in life sciences industry. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/viral-inactivation-market/ Kits &
Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug Therapy Industry …
Anti-viral drug therapy market comprises of sales of branded & generic anti-viral drugs and related services by entities that manufacture the branded or generic anti-viral drugs for treating microbial infections. Anti-viral drug therapy industry includes several establishments that manufacture anti-viral drugs, which are used to treat diseases caused by viral infections. Examples of antiviral drugs include cidofovir, amantadine, zanamivir, idoxuridine, famiciclovir, tenofovir, adefovir and ribavirin. According to study, “Anti-Viral Drug Therapy
Viral Antigens Market to Reap Excessive Revenues by 2028(Based on product type, …
Antigens are commonly referred to as substances that are capable of triggering an immune response in a host by activating the lymphocytes or initiating antibody production against infections. Depending upon the fact that they either enter the human body or originate within the body, viral antigens are classified as foreign or self-antigens respectively. Among these, self-antigens comprise mutated or overexpressed proteins. However, foreign antigens are likely to include bacteria, parasites,
Viral Vector and Plasmid DNA Manufacturing Market - Increase In Awareness Regard …
The Viral Vector and Plasmid DNA Manufacturing Market is expected to reach $ 1,090 million in 2023, growing at an annual average rate of 22.6% from 2017 to 2023. North America was the largest contributor to the viral vector and plasmid DNA markets in 2016. However, the Asia Pacific region is expected to have the highest growth rate during the forecast period. Gene therapy has included tools such as viral vectors
Viral Vaccines Market : Challenges and Opportunities Against Viral Diseases
Vaccines are biotic compositions. They are basically formulated from living beings that increase the resistance against a specific illness. Vaccinations that help in avoiding the occurrence of specific diseases are known as prophylactic vaccines and in other instance, the vaccines that are helpful in treating the disease are called therapeutic vaccines. A vaccine is generally produced by using a weakened or murdered type of the sickness causing microorganism. The agent
Global Viral Molecular Diagnostics Market
The Viral Molecular Diagnostics Market reportprovides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. Viral molecular diagnostic helps in